SS-31 (Elamipretide) Explained: A Mitochondrial Peptide in Late-Stage Trials

You may have encountered SS-31 in a longevity blog, a biohacking forum, or — if you searched long enough — listed in the catalog of a grey-market peptide vendor. The pitch is usually some version of: "mitochondrial optimizer, clinically tested, fights aging at the cellular level." The reasonable question is whether any of that reflects

SS-31 (Elamipretide) Explained: A Mitochondrial Peptide in Late-Stage Trials Read More »

Lion’s Mane for Anxiety: The Nagano 2010 Menopause Trial and Where the Evidence Sits

If you've been searching "lion's mane for anxiety," the short answer is: one small human RCT suggests it may help in menopausal women, but the evidence base is too thin to generalize. This article breaks down exactly what that trial found, what the proposed biological mechanism looks like, and how lion's mane compares to other

Lion’s Mane for Anxiety: The Nagano 2010 Menopause Trial and Where the Evidence Sits Read More »

Ashwagandha Side Effects: The Complete 2026 Reference for Withania somnifera

If you're searching "ashwagandha side effects," you already suspect the botanical wellness narrative may be leaving something out. The honest answer is: ashwagandha is generally well-tolerated at clinical doses, but it carries a documented risk profile that most supplement marketing ignores — including thyroid disruption, liver injury case reports, autoimmune flare potential, and meaningful drug

Ashwagandha Side Effects: The Complete 2026 Reference for Withania somnifera Read More »

Scroll to Top